HomeKYMR • NASDAQ
add
Kymera Therapeutics Inc
Previous close
$67.88
Day range
$65.99 - $68.24
Year range
$19.45 - $68.80
Market cap
4.81B USD
Avg Volume
688.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.76M | -26.12% |
Operating expense | 17.34M | 12.17% |
Net income | -82.18M | -31.51% |
Net profit margin | -2.97K | -77.99% |
Earnings per share | -0.94 | -14.63% |
EBITDA | -85.82M | -23.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 505.68M | -8.05% |
Total assets | 1.10B | 6.49% |
Total liabilities | 155.79M | 9.78% |
Total equity | 946.26M | — |
Shares outstanding | 71.95M | — |
Price to book | 5.15 | — |
Return on assets | -19.85% | — |
Return on capital | -21.24% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -82.18M | -31.51% |
Cash from operations | -27.11M | 45.99% |
Cash from investing | -235.30M | -49.23% |
Cash from financing | 39.51M | -84.25% |
Net change in cash | -222.90M | -617.79% |
Free cash flow | -13.48M | 50.74% |
About
Founded
2015
Headquarters
Website
Employees
225
